DR info

臨床試験数 : 4 / 薬物数 : 5 - (DrugBank : 4) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 14

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Dabigatran
   Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
      2012   -   JPRN-UMIN000015319   Japan;
Gold
   Affiliated Hospital of Xuzhou Medical University
      2018   -   ChiCTR1800017925   -
Rivaroxaban
   The First Affiliated Hospital of Zhengzhou University
      2022   -   ChiCTR2100046725   China;
   University of Insubria
      2020   Phase 4   EUCTR2014-005162-29-NL   Canada;France;Germany;Italy;Netherlands;
Warfarin
   The First Affiliated Hospital of Zhengzhou University
      2022   -   ChiCTR2100046725   China;